Doctors, nurses, and other hospital workers wash their hands thoroughly and often to avoid spreading germs. According to a new study from the University of Michigan, patients should probably do the same. The study,…
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chimerix shares jumped sharply on Tuesday after the firm announced that it would be making changes to its executive team.
Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment of seizures associated with Dravet syndrome.
PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.
Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA interference therapeutics for a broad range of diseases.
Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.
Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs as well as conducting layoffs.
The FDA has issued a safety alert related to the use of e-cigarettes, especially among young Americans. The agency has received a number of reports that mentioned seizures having occurred while vaping.
Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.
Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model of Parkinson’s disease.
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
A new study on prescription opioid use in the United States finds that while dosages and amounts are dropping, longer-term prescriptions and prescriptions lasting longer than 30 days are rising. And Americans continue dying.
